On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Integrated Oncology (United States)

InstitutionResearch output, impact & collaborations

Integrated Oncology (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Integrated Oncology (United States)?

ScholarIQrecord summary

Integrated Oncology (United States) is a research organisation in Durham, US. OpenAlex records 2,629 works and 255,967 citations for it. 1,024 researchers list it as their most recent affiliation.

How many works does Integrated Oncology (United States) have?

ScholarIQindexed works

Integrated Oncology (United States) has 2,629 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Integrated Oncology (United States) →

How many citations does Integrated Oncology (United States) have?

ScholarIQcitation count

Integrated Oncology (United States) has 255,967 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Integrated Oncology (United States) →

How many researchers are at Integrated Oncology (United States)?

ScholarIQresearcher count

Integrated Oncology (United States) has 1,024 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Integrated Oncology (United States)?

ScholarIQavg h-index

Integrated Oncology (United States) has an average h-index of 80.3 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Integrated Oncology (United States)?

ScholarIQror

The ROR for Integrated Oncology (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Integrated Oncology (United States)?

ScholarIQopenalex

The OpenAlex for Integrated Oncology (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Integrated Oncology (United States)?

ScholarIQtop researchers by citations

Wolfgang Wagner · Epigenetics and DNA Methylation

557 works46,090 citations

Jean‐Yves Douillard · Colorectal Cancer Treatments and Studies

383 works33,552 citations

David Crews · Animal Behavior and Reproduction

368 works18,313 citations

What are the most-cited papers on Integrated Oncology (United States)?

ScholarIQmost cited works

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Martin Reck, R. Kaiser, Anders Mellemgaard, Jean‐Yves Douillard, С. В. Орлов, Maciej Krzakowski, Joachim von Pawel, Maya Gottfried, Igor Bondarenko, Meilin Liao, Claudia-Nanette Gann, José Barrueco, Birgit Gaschler‐Markefski, Silvia Novello

The Lancet Oncology. 2014950 CitationsOPEN ACCESS

Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, George Pentheroudakis, Kentaro Yamazaki, Rui‐Hua Xu, Tae‐Woo Kim, Muhammad Ismail, Iain Tan, Kun‐Huei Yeh, Axel Grothey, S. Zhang, Joong Bae Ahn, M.Y. Mastura, Dawn Q. Chong, Liqun Chen, Scott Kopetz, Takako Eguchi-Nakajima, Hiromichi Ebi, Atsushi Ohtsu, Andrés Cervantes, Kei Muro, Josep Tabernero, Hironobu Minami, Fortunato Ciardiello, Jean‐Yves Douillard

Annals of Oncology. 2017596 CitationsOPEN ACCESS

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Primo N. Lara, Jean‐Yves Douillard, Kazuhiko Nakagawa, Joachim von Pawel, Mark J. McKeage, István Albert, György Losonczy, Martin Reck, Dae Seog Heo, Xiaolin Fan, Abderrahim Fandi, Giorgio V. Scagliotti

Journal of Clinical Oncology. 2011321 CitationsOPEN ACCESS

How much of the research on Integrated Oncology (United States) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

33%

Hybrid

Bronze

67%

Closed